OXLABS, an AI and care-tech company on a mission to improve the quality of life for the elderly in Britain, announced its partnership with NTT PARAVITA, a Japanese technology company that provides healthcare services aimed at improving essential sleep.
NTT PARAVITA is a joint venture between NTT West, a division of one of the largest telecom companies in the world and Paramount Bed, which boasts the top market share in Japan for medical beds and under-mattress sleep sensors.
OXLABS is developing HABITA (trademarked), the world’s most advanced in-room wellness monitoring system using the next generation of AI to improve the wellbeing of the elderly and support pre-symptomatic detection of disease.
The partnership aligns the mission of both companies to utilise groundbreaking technology to address sleep issues in local communities which are closely linked with conditions such as cardiac problems, dementia, and diabetes.
According to the Sleep Foundation, between 40% and 70% of older adults have chronic sleep issues and up to half of cases may be undiagnosed.
The first product the partnership will bring to the UK will be NTT PARAVITA’s under-mattress sleep sensor product which is already well established in Japan.
CEO of OXLABS, Katrina Douglas said: “We are delighted to partner with such a well-established and trusted Japanese company as NTT PARAVITA. With one of the oldest populations in the world, Japan has advanced expertise in addressing sleep challenges in the UK. We believe the combination of our HABITA solution and NTT PARAVITA’s sleep sensor represents an effective and much-needed offering for the UK market.”
General Manager of NTT PARAVITA, Yasuo Makibayashi said: “We chose OXLABS as our trial partner for the UK because of their technical expertise, innovative solution and market development approach. We also value the calibre of the team with Mike Lawton having founded and invested in one of the fastest growing spacetech startups in the UK and now OXLABS. The team has more than 80 years of combined business leadership experience, and we saw the degree of their knowledge from the beginning and are delighted to be launching our products with OXLABS in the UK."
We chose OXLABS as our trial partner for the UK because of their technical expertise, innovative solution and market development approach.
OXLABS was part of the first Healthy Ageing Accelerator delivered by The National Innovation Centre for Ageing (NICA). This helped cultivate a culture of international expansion within the company and influenced the go-to-marketing strategy.
In full support of the partnership, Director of the UK’s National Innovation Centre for Ageing, Nic Palmarini said: “There is a radical need for innovation in ageing and longevity. Our work with OXLABS reflects our strategy of supporting both companies and the whole industry to develop intelligence centred on data and people's desires by integrating those innovations - process or technological - that accelerate the development of solutions for our healthy longevity. These innovations matter to a global audience, which is why we have been active from the start in supporting OXLABS' journey to help make their solution a reference."